Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sample Size Calculation01:19

Sample Size Calculation

7.0K
Knowledge of the sample size is the first requirement to conduct random sampling or an experiment. The sample size is the total number of units, observations, or groups (in some cases) used to get the data to estimate a population parameter. As the name suggests, the sample size is that of the sample drawn from the population and differs from the population size.
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
7.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

556
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
556
Contaminants and Errors01:16

Contaminants and Errors

609
Effective sample preparation is crucial for accurate and reliable laboratory analysis. During this process, two significant sources of error can arise: concentration bias from improper sample splitting and contamination caused by methods used to reduce particle size, such as grinding or homogenization. Identifying and minimizing these potential errors is crucial to ensuring the validity of the analysis.
Another key consideration is determining the appropriate number of samples required to...
609
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

7.0K
One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
7.0K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

489
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
489
Sampling Plans01:23

Sampling Plans

1.3K
Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discussion on "Adaptive enrichment designs with a continuous biomarker" by N. Stallard.

Biometrics·2022
Same author

Robust group sequential designs for trials with survival endpoints and delayed response.

Biometrical journal. Biometrische Zeitschrift·2021
Same author

Optimizing subgroup selection in two-stage adaptive enrichment and umbrella designs.

Statistics in medicine·2021
Same author

Adaptive enrichment trials: What are the benefits?

Statistics in medicine·2020
Same author

Authors' reply.

Statistics in medicine·2019
Same author

Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies.

Clinical trials (London, England)·2017

Related Experiment Video

Updated: Apr 7, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Adaptive sample size modification in clinical trials: start small then ask for more?

Christopher Jennison1, Bruce W Turnbull2

  • 1Department of Mathematical Sciences, University of Bath, Bath, U.K.

Statistics in Medicine
|July 15, 2015
PubMed
Summary

This study analyzes sample size re-estimation in clinical trials with delayed patient response, identifying pitfalls in existing methods and proposing more efficient rules for increasing sample size when new data is most beneficial.

Keywords:
adaptive designclinical trialgroup sequential testoptimal designpromising zonesample size re-estimation

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Related Experiment Videos

Last Updated: Apr 7, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Medical Research Methodology

Background:

  • Sample size re-estimation is crucial in clinical trials, especially with delayed patient response.
  • Existing methods, like Mehta and Pocock's 'promising zone,' have potential application pitfalls.

Purpose of the Study:

  • To analyze the limitations of current sample size re-estimation methods in clinical trials.
  • To propose improved sample size adjustment rules for enhanced trial efficiency and power.

Main Methods:

  • Analysis of existing sample size re-estimation methodologies, including those by Mehta and Pocock.
  • Development of new sample size rules based on the principle of maximizing the benefit of additional observations.

Main Results:

  • Identified inefficiencies in the 'promising zone' approach, where maximum power gains may lie outside defined regions.
  • Demonstrated that moderate sample size increases over a wider range of outcomes are more efficient than large increases for narrow outcome ranges.

Conclusions:

  • The framework for sample size re-estimation is valuable but requires careful application to avoid pitfalls.
  • Proposed sample size rules offer a more efficient approach to adaptive clinical trial design, particularly for delayed responses.